Neuroscience · 2019 · 30 citations · 32 references
MedicineNeurobiologyNeuroscienceCellular NeuroscienceGlial BiologyNeuroimmunologyAstrocyte BiologyGlial Cell BiologyGlial Cell Molecular BiologyNervous TissueNeuroinflammationReactive GliosisAstrocyte Immune MetabolismAstrocyte ImmunologyAstrocyte Innate Immune ResponsesAstrocyte NeuroinflammationAstrocyte PhysiologyAstrocyte-mediated ImmunomodulationAstrocyte-mediated ImmunoregulationExperimental Autoimmune Encephalomyelitis
Fatty acid binding protein 7 (FABP7) is expressed in astrocytes of the developing and mature central nervous system, and modulates astrocyte function by controlling intracellular fatty acid homeostasis. Astrocytes in the spinal cord have an important role in the process of myelin degeneration and regeneration. In the present study, the authors examined the role of FABP7 in astrocytes in a mouse model of experimental autoimmune encephalomyelitis (EAE), which is an established model of multiple sclerosis (MS). FABP7 was expressed in the white matter astrocytes and increased after EAE onset; particularly strong expression was observed in demyelinating regions. In FABP7-knockout (KO) mice, the onset of EAE symptoms occurred earlier than in wild type (WT) mice, and mRNA expression levels of inflammatory cytokines (IL-17 and TNF-α) were higher in FABP7-KO lumbar spinal cord than in WT lumbar spinal cord at early stage of EAE. Interestingly, however, the clinical score was significantly reduced in FABP7-KO mice compared with WT mice in the late phase of EAE. Moreover, the area exhibiting expression of fibronectin, which is an extracellular matrix protein mainly produced by astrocytes and inhibits remyelination of oligodendrocytes, was significantly decreased in FABP7-KO compared with WT mice. Collectively, FABP7 in astrocyte may have a role to protect from the induction of inflammation leading to demyelination in CNS at early phase of EAE. Moreover, FABP7 may be involved in the regulation of fibronectin production through the modification of astrocyte activation at late phase of EAE.
32
Masamitsu Hara, Kazu Kobayakawa, Yasuyuki Ohkawa et al. · Nature Medicine · 2017 · 565 citations · Full text
Medicine, Cell Biology, Neuroscience +17
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination
Lorraine Lau, Michael B. Keough, Sarah Haylock‐Jacobs et al. · Annals of Neurology · 2012 · 245 citations · Full text
Medicine, Neurology, Neuroscience +17